Adam Muzikant, Chief Business Officer at Flexion Therapeutics Inc (FLXN), sold 1,870 shares at $6.45 ($12K) on 2021-07-19, disclosed to the SEC on 2021-07-20.
Open-market sale of $12k FLXN by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.